liraglutide to semaglutide File:Semaglutide vs. v01 SVK.png Liraglutide vs. Semaglutide For Weight

Quick service thank you

If you are taking medication for thyroid or cardiovascular conditions, seek medical advice before use

Releasing Q2 earnings on Monday, Hims & Hers Co-Founder and CEO Andrew Dudem said users of its personalized GLP-1 treatment plans had lost an average 10.3% of their body weight over six months, and that only 25% of them had discontinued treatment, particularly encouraging when considering discontinuation rates in certain publicly available studies reached approximately 80% percent by six months. Saying that personalized treatments allow patients to receive clear treatment instructions and educational content while also accessing tools such as water intake trackers and calorie counters, Dudem complained of pushback from traditional incumbents. During its own earnings call on Wednesday, Novo Nordisk doubled down against GLP-1 compounders that it says are still around despite the end of an FDA-granted grace period in May

Drue GE, Hurley S, Minor RC

In one study, integrating ePA into the prescribing workflow yielded over 80% faster turnaround times and 10-hour faster submission turnaround on average ( [7] )